Stephen Thompson
Chairman bij OncoRes Medical Pty Ltd.
Profiel
Stephen Thompson is currently the Chairman at OncoRes Medical Pty Ltd.
He is also a Founding Partner & Managing Director at Brandon Capital Partners Pty Ltd.
In addition, he holds director positions at Elastagen Pty Ltd., Vaxxas Pty Ltd., MiReven Pty Ltd., MecRx Pty Ltd., Myricx Pharma Ltd., Respirion Pharmaceuticals Pty Ltd., and is a member of AusBiotech Ltd.
Previously, Dr. Thompson served as Chairman at Longas Technologies Pty Ltd.
He was also a Director at Apax Partners LLP, Cancer Therapeutics CRC Pty Ltd., Heart Metabolics Ltd., Helmedix Pty Ltd., and Auspherix Ltd.
Additionally, he worked as a Principal at Cantab Pharmaceuticals Plc.
Dr. Thompson obtained an MBA from Imperial College London.
He also completed undergraduate and doctorate degrees from King's College London.
Actieve functies van Stephen Thompson
Bedrijven | Functie | Begin |
---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Private Equity Investor | 01-01-2007 |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Director/Board Member | 20-01-2010 |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Director/Board Member | - |
MiReven Pty Ltd.
MiReven Pty Ltd. Pharmaceuticals: MajorHealth Technology MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia. | Director/Board Member | - |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Corporate Officer/Principal | - |
OncoRes Medical Pty Ltd.
OncoRes Medical Pty Ltd. Medical SpecialtiesHealth Technology OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia. | Chairman | - |
MecRx Pty Ltd.
MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Respirion Pharmaceuticals Pty Ltd.
Respirion Pharmaceuticals Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia. | Director/Board Member | - |
Myricx Pharma Ltd.
Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | - |
Eerdere bekende functies van Stephen Thompson
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Stephen Thompson
Imperial College London | Masters Business Admin |
King's College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 16 |
---|---|
Cantab Pharmaceuticals Plc
Cantab Pharmaceuticals Plc MiscellaneousMiscellaneous Cantab Pharmaceuticals plc, based in Cambridge, England, was established in 1989 to exploit advances in immunology. Since that time, Cantab has become a leader in the areas of immunotherapy and gene delivery and has developed a broad portfolio of novel products for the treatment and prevention of many chronic infectious diseases, cancer and substance addiction. | Miscellaneous |
Apax Partners LLP
Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Finance |
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Health Technology |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Health Technology |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Helmedix Pty Ltd.
Helmedix Pty Ltd. Pharmaceuticals: MajorHealth Technology Helmedix Pty Ltd. develops novel therapies for autoimmune diseases. It uses peptides derived from helminthes parasite to treat rheumatoid arthritis, colitis, psoriasis and multiple sclerosis. The company was founded by Andrew Hutchinson on December 1, 2012 and is headquartered in Melbourne, Australia. | Health Technology |
MiReven Pty Ltd.
MiReven Pty Ltd. Pharmaceuticals: MajorHealth Technology MiReven Pty Ltd. operates as an Australian biopharmaceutical company. The private company is based in Nedlands, Australia. | Health Technology |
MecRx Pty Ltd.
MecRx Pty Ltd. Pharmaceuticals: MajorHealth Technology MecRx Pty Ltd. develops drugs for treatment of cancer. The company was founded by Ian Holmes, Jo Alcindor, Tom Peat and Janet Newman in 2013 and is headquartered in Melbourne, Australia. | Health Technology |
OncoRes Medical Pty Ltd.
OncoRes Medical Pty Ltd. Medical SpecialtiesHealth Technology OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia. | Health Technology |
Longas Technologies Pty Ltd.
Longas Technologies Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia. | Commercial Services |
Myricx Pharma Ltd.
Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Respirion Pharmaceuticals Pty Ltd.
Respirion Pharmaceuticals Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia. | Commercial Services |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | Health Technology |